跳至主要内容
临床试验/NCT01919580
NCT01919580Unknown不适用

Observational Study on the Carcinogenesis of Gα12 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer Using Ga12 Inhibitor.

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 255 人开始时间: 2012年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
255
试验地点
1
主要终点
Carcinogenesis of Gα12

研究概览

简要总结

Study on the carcinogenesis of Gα12 in oral cancer, and chemopreventive possibility for the treatment of oral cancer using Ga12 inhibitor.

详细描述

To find out if there is prognostic value which to the performance of Gα12 of oral cancer in Taiwan and provide some reference for future treatment.

We anticipate to enroll 40 persons with normal oral mucosa, 65 persons with oral dysplasia and 150 persons with oral cancer and collect the tissue which was stained for pathological sections over a 3 year period.

We also collect the blood and saliva samples from patients and the results along with patient-specific information such as tumor phases, tumor size, lymph node metastasis, cancer metastasis, prognosis and betel nut chewing, smoking and drinking habits and other parameters are statistically analyzed.

研究设计

研究类型
Observational
观察模型
Case Control

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Dysplasia or cancer of the oral cavity.

排除标准

  • pregnant woman

结局指标

主要结局

Carcinogenesis of Gα12

时间窗: 3 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验